Christina A. Ortmann

3.6k total citations · 1 hit paper
10 papers, 756 citations indexed

About

Christina A. Ortmann is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Christina A. Ortmann has authored 10 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Christina A. Ortmann's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Christina A. Ortmann is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Christina A. Ortmann collaborates with scholars based in Germany, United Kingdom and Spain. Christina A. Ortmann's co-authors include Florian Seeger, Tobias Schmid, Hubert Serve, Birgit Aßmus, Jedrzej Hoffmann, Bernhard Brüne, Michael A. Rieger, Tina Rasper, Andreas M. Zeiher and Sebastian Wagner and has published in prestigious journals such as Nucleic Acids Research, Blood and Haematologica.

In The Last Decade

Christina A. Ortmann

10 papers receiving 744 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure

2018 326 citations Lena Dorsheimer, Birgit Aßmus et al. JAMA Cardiology profile →

Peers

Countries citing papers authored by Christina A. Ortmann

Since Specialization

Citations

This map shows the geographic impact of Christina A. Ortmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina A. Ortmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina A. Ortmann more than expected).

Fields of papers citing papers by Christina A. Ortmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina A. Ortmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina A. Ortmann. The network helps show where Christina A. Ortmann may publish in the future.

Co-authorship network of co-authors of Christina A. Ortmann

This figure shows the co-authorship network connecting the top 25 collaborators of Christina A. Ortmann. A scholar is included among the top collaborators of Christina A. Ortmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina A. Ortmann. Christina A. Ortmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure breakdown → 2018 ·JAMA Cardiology ·Lena Dorsheimer, Birgit Aßmus, Tina Rasper, Christina A. Ortmann, (unknown), Khalil Abou‐El‐Ardat, Tobias Schmid, Bernhard Brüne, Sebastian Wagner, Hubert Serve, Jedrzej Hoffmann, Florian Seeger, Stefanie Dimmeler, Andreas M. Zeiher, Michael A. Rieger	326
2	Second-Line Systemic Therapy for Metastatic Urothelial Carcinoma of the Bladder 2013 ·Future Oncology ·Christina A. Ortmann, Danish Mazhar	14
3	Order Matters: Sequence Of Mutation Acquisition In Myeloproliferative Neoplasms Impacts Disease Pathogenesis and Stem Cell Potency 2013 ·Blood ·David G. Kent, Christina A. Ortmann, Yvonne Silber, E. Joanna Baxter, Beatríz Bellosillo, Konstanze Doehner, Peter J. Campbell, Anthony R. Green	1
4	JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone 2012 ·Blood ·Anna L. Godfrey, Edwin Chen, Francesca Pagano, Christina A. Ortmann, Yvonne Silber, Beatríz Bellosillo, Paola Guglielmelli, Claire Harrison, John T. Reilly, Frank Stegelmann, Fontanet Bijou, Éric Lippert, Mary Frances McMullin, Jean‐Michel Boiron, Konstanze Döhner, Alessandro M. Vannucchi, Carlos Besses, Peter J. Campbell, Anthony R. Green	68
5	Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms 2011 ·Blood ·Shubha Anand, (unknown), Philip Beer, Emma Gudgin, Christina A. Ortmann, Anthony J. Bench, Wendy N. Erber, Anthony R. Green, Brian J.P. Huntly	51
6	Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations 2011 ·Blood ·Francesco Passamonti, Chiara Elena, Susanne Schnittger, Radek C. Skoda, Anthony R. Green, François Girodon, Jean‐Jacques Kiladjian, Mary Frances McMullin, Marco Ruggeri, Carles Besses, Alessandro M. Vannucchi, Éric Lippert, Heinz Gisslinger, Elisa Rumi, Thomas Lehmann, Christina A. Ortmann, Daniela Pietra, Cristiana Pascutto, Torsten Haferlach, Mario Cazzola	166
7	Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasms 2010 ·Haematologica ·Philip Beer, Christina A. Ortmann, Frank Stegelmann, Paola Guglielmelli, John T. Reilly, Thomas Stauffer Larsen, Hans Carl Hasselbalch, (unknown), Per Werner Möller, Konstanze Döhner, Anthony R. Green	17
8	Aberrant hypomethylation of the cancer–testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia 2008 ·Annals of Hematology ·Christina A. Ortmann, Lewin Eisele, Holger Nückel, Ludger Klein‐Hitpaß, Anja Führer, Ulrich Dührsen, Michael Zeschnigk	52
9	TERC mutations in children with refractory cytopenia. 2006 ·PubMed ·Christina A. Ortmann, Charlotte M. Niemeyer, Angela Wawer, Wolfram Ebell, Irith Baumann, Christian P. Kratz	26
10	Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region 2005 ·Nucleic Acids Research ·Christina A. Ortmann	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact